LEGEND BIOTECH CORP-ADR (LEGN) Forecast, Price Target & Analyst Ratings

NASDAQ:LEGN • US52490G1022

Current stock price

21.17 USD
+0.09 (+0.43%)
At close:
21.17 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LEGEND BIOTECH CORP-ADR (LEGN).

Forecast Snapshot

Consensus Price Target

Price Target
$63.80
+ 201.37% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.03
Revenue Estimate
312.36M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
83.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$63.80
Upside
+ 201.37%
From current price of $21.17 to mean target of $63.80, Based on 24 analyst forecasts
Low
$21.21
Median
$64.26
High
$95.55

Price Target Revisions

1 Month
-3.04%
3 Months
-11.47%

Price Target Summary

24 Wall Street analysts provided a forecast for the next 12 months for LEGN. The average price target is 63.8 USD. This implies a price increase of 201.37% is expected in the next year compared to the current price of 21.17.
The average price target has been revised downward by 11.47% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

LEGN Current Analyst RatingLEGN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

LEGN Historical Analyst RatingsLEGN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 10 20 30

Analyst Ratings Consensus

ChartMill Buy Consensus
83.33%
LEGN was analyzed by 24 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about LEGN.
In the previous month the buy percentage consensus was at a similar level.
LEGN was analyzed by 24 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-15HC Wainwright & Co.Reiterate Buy -> Buy
2026-03-11RBC CapitalMaintains Outperform -> Outperform
2026-03-11Morgan StanleyMaintains Overweight -> Overweight
2026-02-04BarclaysMaintains Overweight -> Overweight
2026-01-22TD CowenDowngrade Buy -> Hold
2026-01-22HC Wainwright & Co.Maintains Buy -> Buy
2026-01-20RBC CapitalMaintains Outperform -> Outperform
2026-01-07OppenheimerInitiate Outperform
2025-12-17Cantor FitzgeraldMaintains Overweight -> Overweight
2025-12-12Morgan StanleyMaintains Overweight -> Overweight
2025-12-08UBSMaintains Buy -> Buy
2025-11-13Cantor FitzgeraldMaintains Overweight -> Overweight
2025-11-13RBC CapitalMaintains Outperform -> Outperform
2025-11-13BarclaysMaintains Overweight -> Overweight
2025-10-17HC Wainwright & Co.Maintains Buy -> Buy
2025-10-09JP MorganMaintains Overweight -> Overweight
2025-08-25JP MorganMaintains Overweight -> Overweight
2025-08-12RBC CapitalMaintains Outperform -> Outperform
2025-08-12Morgan StanleyMaintains Overweight -> Overweight
2025-07-17HC Wainwright & Co.Reiterate Buy -> Buy
2025-07-10Morgan StanleyMaintains Overweight -> Overweight
2025-07-08HC Wainwright & Co.Reiterate Buy -> Buy
2025-07-02UBSMaintains Buy -> Buy
2025-05-14Cantor FitzgeraldReiterate Overweight -> Overweight
2025-05-14Truist SecuritiesMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.03
Revenue Estimate
312.36M
Revenue Q2Q
60.14%
EPS Q2Q
94.64%
Number of Analysts
14

Next Earnings Revisions

Revenue (1 Month)
-0.86%
Revenue (3 Months)
-6.89%
EPS (1 Month)
-78.72%
EPS (3 Months)
-127.04%

Next Earnings Summary

LEGN is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.03 USD and the consensus revenue estimate is 312.36M USD.
The next earnings revenue estimate has been revised downward by 6.89% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
LEGN revenue by date.LEGN revenue by date.
285.143M
143.71%		627.241M
119.97%		1.029B
64.04%		1.468B
42.68%		1.916B
30.52%		2.28B
19.00%		2.453B
7.59%		2.687B
9.54%		2.894B
7.70%		3.073B
6.19%		3.237B
5.34%
EBITDA
YoY % growth
LEGN ebitda by date.LEGN ebitda by date.
-507.515M
-15.42%		-281.789M
44.48%		-107.6M
61.82%		139.11M
229.28%		422.43M
203.67%		608.16M
43.97%		886.24M
45.72%		1.037B
17.01%		1.148B
10.70%		1.235B
7.58%		1.303B
5.51%
EBIT
YoY % growth
LEGN ebit by date.LEGN ebit by date.
-527.966M
-15.25%		-305.148M
42.20%		-136.5M
55.27%		115.08M
184.31%		411.49M
257.57%		718.99M
74.73%		1.021B
42.00%		1.205B
18.02%		1.323B
9.79%		1.411B
6.65%		1.489B
5.53%
Operating Margin
LEGN operating margin by date.LEGN operating margin by date.
-185.16%-48.65%-13.27%7.84%21.48%31.53%41.62%44.85%45.72%45.92%46.00%
EPS
YoY % growth
LEGN eps by date.LEGN eps by date.
-2.96
-100.97%		-0.95
67.91%		-1.60
-68.42%		0.20
112.43%		1.13
466.53%		2.03
79.86%		1.99
-1.89%		3.36
68.77%		3.50
4.41%		3.86
10.19%		N/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.03
94.64%		0.02
103.08%		0.08
134.60%		0.12
176.42%		0.23
880.48%		0.33
1,458.54%		0.49
541.83%		0.50
308.32%
Revenue
Q2Q % growth		312.36M
60.14%		347.74M
36.34%		381.66M
40.15%		418.26M
36.55%		405.52M
29.82%		423.2M
21.70%		446.46M
16.98%		788.84M
88.60%
EBITDA
Q2Q % growth		14.651M
132.24%		25.96M
339.75%		32.504M
222.56%		39.69M
328.25%		52.928M
261.26%		44.314M
70.70%		48.593M
49.50%		96.569M
143.31%
EBIT
Q2Q % growth		-4.617M
90.88%		9.34M
142.69%		25.29M
158.20%		41.856M
313.20%		40.229M
971.25%		41.704M
346.51%		57.735M
128.29%		94.727M
126.32%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

LEGN Yearly Revenue VS EstimatesLEGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 1B 2B 3B
LEGN Yearly EPS VS EstimatesLEGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
48.38%
EPS Next 5 Year
32.59%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
29.41%
Revenue Next 5 Year
20.63%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
78.96%
EBIT Next 5 Year
52.92%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

LEGEND BIOTECH CORP-ADR / LEGN Forecast FAQ

What is the price target for LEGN stock?

24 analysts have analysed LEGN and the average price target is 63.8 USD. This implies a price increase of 201.37% is expected in the next year compared to the current price of 21.17.

Can you provide the upcoming earnings date for LEGEND BIOTECH CORP-ADR?

LEGEND BIOTECH CORP-ADR (LEGN) will report earnings on 2026-05-11, before the market open.

What are the consensus estimates for LEGN stock next earnings?

The consensus EPS estimate for the next earnings of LEGEND BIOTECH CORP-ADR (LEGN) is -0.03 USD and the consensus revenue estimate is 312.36M USD.

What is the expected long term growth rate for LEGN stock?

The expected long term growth rate for LEGEND BIOTECH CORP-ADR (LEGN) is 29.41%.